Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christian F Singer Michael Krainer |
| Publication date | March 1, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |